This project of the gene therapy center grant is focused on developing and testing practical techniques for administering genes to the lungs. The project will evaluate the efficiency of delivery of gene vectors to the lungs of adult rabbits by installation and aerosolization techniques. Aerosolized adenovirus will be studied to evaluate the infectivity as a function of particle size and type of aerosol generator. The quantity of vector delivered to the lungs will be measured, and the efficiency of gene expression then will be measured using a reporter gene. The distribution of gene expression along the airways will be evaluated together with the cells types expressing the reporter gene. The initial vector to be studied will be an adenovirus-LacZ construct with beta-gal measured to monitor gene expression. The relative efficiencies of instilled versus aerosolized virus will be quantified, and the possible beneficial effects of surfactant (synthetic lipid and natural surfactant lipid extract) on viral spreading and gene expression will be evaluated. The cell types expressing the gene product will be evaluated by histologic and in situ techniques to achieve adequate gene expression are in hand, the time course of gene expression and possible lung toxicity will be determined. These measurements then will be repeated using an adenovirus construct containing the human CFTR gene and using plasmid and protein-DNA conjugate-vectors. The overall goal is to identify the best administration techniques to deliver vectors to the lungs that will result in efficient and persistent expression of CFTR.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051832-03
Application #
3737214
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Wert, Susan E; Whitsett, Jeffrey A; Nogee, Lawrence M (2009) Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 12:253-74
Zsengeller, Z K; Ross, G F; Trapnell, B C et al. (2001) Adenovirus infection increases iNOS and peroxynitrite production in the lung. Am J Physiol Lung Cell Mol Physiol 280:L503-11
Zeng, X; Gray, M; Stahlman, M T et al. (2001) TGF-beta1 perturbs vascular development and inhibits epithelial differentiation in fetal lung in vivo. Dev Dyn 221:289-301
Iwamoto, H S; Trapnell, B C; McConnell, C J et al. (1999) Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther 6:98-106
Zsengeller, Z K; Halbert, C; Miller, A D et al. (1999) Keratinocyte growth factor stimulates transduction of the respiratory epithelium by retroviral vectors. Hum Gene Ther 10:341-53
Schwarz, Y A; Amin, R S; Stark, J M et al. (1999) Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector. Am J Respir Cell Mol Biol 21:388-94
Otake, K; Ennist, D L; Harrod, K et al. (1998) Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther 9:2207-22
Jain-Vora, S; LeVine, A M; Chroneos, Z et al. (1998) Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa. Infect Immun 66:4229-36
Zeng, X; Wert, S E; Federici, R et al. (1998) VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 211:215-27
Weaver, T E (1998) Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1408:173-9

Showing the most recent 10 out of 44 publications